HD Hyundai Chairman Chung Kisun Discusses Future of AI and Energy at Davos Forum
Chairman Chung attends 2026 World Economic Forum Annual Meeting for fourth consecutive year Discusses AI-driven transformation and innovation in energy transition at key sessions Met with Palantir co-founder and CEO Alex Karp to discuss expansion of...
Lynk Pharmaceuticals Announces Positive Phase III Topline Data of Zemprocitinib (LNK01001) in Rheumatoid Arthritis
HANGZHOU, China, SHANGHAI and BOSTON, Jan. 12, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals"), a clinical stage innovative drug development company focused on developing innovative therapies...
MindHYVE Leadership Engages Sacramento Community Through Education, AI Literacy, and Student Empowerment at Miracle University's "Multiply the Miracle" Event
SACRAMENTO, Calif., Jan. 7, 2026 /PRNewswire/ -- At a time when nearly 1 in 5 students nationally fails to complete high school on time and young adults without a diploma face significantly higher unemployment and housing insecurity, MindHYVE.ai™...
Global Times: Xi hears reports from HKSAR, Macao SAR chief executives
BEIJING, Dec. 24, 2025 /PRNewswire/ -- President Xi Jinping on Tuesday met with Chief Executive of the Hong Kong Special Administrative Region (HKSAR) John Lee, and Chief Executive of the Macao Special Administrative Region (SAR) Sam Hou Fai, in...
Precision Medicine Portfolio Update: Illuccix China Phase 3 Study, TLX101-CDx and TLX250-CDx FDA Resubmissions
MELBOURNE, Australia and INDIANAPOLIS, Dec. 22, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today provides a precision medicine portfolio update in relation to: TLX591-CDx (Illuccix® in approved jurisdictions,...
Mazdutide Demonstrates Significant Weight Loss and Metabolic Benefits in Phase 1b Clinical Trial in Chinese Adolescents with Obesity
After 12 weeks of treatment, the 4 mg and 6 mg mazdutide groups achieved reductions in BMI from baseline of 8.78% and 10.99%, respectively, with corresponding body weight reductions of 7.72 kg and 8.65 kg. These results were significantly superior...
Henlius' Serplulimab (anti-PD-1 mAb) Granted Breakthrough Therapy Designation by China NMPA for Neo-/Adjuvant Treatment for Gastric Cancer
The first CDE-designated Breakthrough Therapy for perioperative gastric cancer, promising accelerated patient access. The world's first gastric cancer perioperative regimen replacing chemotherapy with immunotherapy alone in the adjuvant setting has...
XCMG Deepens South America Ties with Localization Push, New Hubs, and Sustainable Mining Partnerships
POUSO ALEGRE, Brazil, Nov. 4, 2025 /PRNewswire/ -- Yang Dongsheng, Chairman of XCMG Machinery, met Brazilian President Lula at the Presidential Palace, with the vice president and chief of staff present. Lula praised XCMG's decade-plus...
China, United States can achieve mutual success, shared prosperity
BEIJING, Oct. 31, 2025 /PRNewswire/ -- A report from People's Daily: On Oct. 30, Chinese President Xi Jinping met with his U.S. counterpart Donald Trump in Busan, South Korea. The two heads of state held in-depth discussions on strategic and...
Global Times: Xi says ready to work with Trump to build solid foundation for bilateral ties
BEIJING, Oct. 31, 2025 /PRNewswire/ -- Chinese President Xi Jinping met on Thursday with US President Donald Trump to exchange views on bilateral relations and issues of mutual interest in Busan, South Korea, the Xinhua News Agency reported....